Merciful Genocide: Big Pharma Cut Vaccine Prices for the Poor

Several major drugs companies have announced big cuts to the amounts they charge for their vaccines in the developing world. Birth control and forced sterilization through vaccinations is one of the most effective forms of Eugenics.

BBC
June 7, 2011

EUGENICS: The Elitist’s War on Humanity. Doing Nothing is Not an Option!

GlaxoSmithKline (GSK), Merck, Johnson & Johnson and Sanofi-Aventis have agreed to cut prices through the international vaccine alliance Gavi.

GSK said it would cut the price of its vaccine for rotavirus by 67% to $2.50 (£1.50) a dose in poor countries.

Rotavirus-related diarrhoea kills more than 500,000 children a year.

The vaccine will be subsidised by higher prices being charged in richer countries.

The rotavirus vaccine, for example, would cost about $50 in the US.

‘Helped out’

“What we need is a return to invest in the next generation of new vaccines and drugs and that has to come from the profits of the medicines or the vaccines,” Andrew Witty, chief executive of GSK told the BBC.

“But it’s obvious that if you’re in Kenya or a slum in Malawi or somewhere like that there is no capacity for those people to contribute to it, so they have to be helped out by the contribution from the middle and the richer (countries).”

Gavi is a partnership representing public and private sector organisations that helps to fund mass vaccination programmes in developing countries.

It is committed to funding the introduction of rotavirus vaccinations in 40% of the poorest countries by 2015, but it faced a $3.7bn funding shortfall and so has been appealing for price cuts and donations.

It will be holding a pledging conference in London on 13 June.

Anti-poverty campaigners welcomed the move but also called on world leaders to act.

“The pricing commitments announced today help drive momentum, but Gavi’s ambition to save four million lives in the next five years is only achievable if the international donor community steps up to the plate on 13 June,” said Jamie Drummond, executive director of campaign group ONE.

Malaria vaccine

Merck has said it will provide its own rotavirus vaccine for $5 a dose, coming down to $3.50 once more than 30 million doses have been sold.

The price Gavi pays for pentavalent vaccines, which protect against diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B will be cut by two Indian firms, Serum Institute and Panacea Biotec.

GSK also said it was very close to developing the world’s first malaria vaccine, which is unusual because there is no market for it in the West.

That means there is no opportunity for patients in richer countries to subsidise those in poorer countries.

As a result, GSK said that if the vaccine comes to market it would be sold at a price that provides a small return of 5%, which would be used to fund the next generation of malaria treatments.

Save the Children called on other companies to replicate the “landmark move” which it said could prevent hundreds of thousands of “needless deaths”.

“It’s important that Gavi now uses this to spur other vaccine producers to reduce prices and work to foster greater competition amongst producers to drive prices down even further and help even more children,” said chief executive Justin Forsyth.

Israeli American Microbiologist Linked to Deadly Fungus Cryptococcus

Infowars

The strange case of Joseph Moshe has resurfaced.

In August of 2009, Moshe was accused of making threats against the White House. He briefly made headlines during a stand-ofcryptococcusf with police in Los Angeles. During the confrontation, the Israeli scientist remarkably withstood five rounds of chemical agent tossed inside his car in the parking lot of the Federal Building in West Los Angeles.

It was later learned that Moshe had called into a radio talk show and said he wanted to supply evidence regarding tainted H1N1 swine flu vaccines being produced by Baxter BioPharma Solutions. Moshe claimed a Baxter lab in Ukraine was producing a bioweapon that would be passed off as a vaccine. He said the vaccine contained an adjuvant engineered to weaken the immune system. Replicated RNA from the virus, Moshe insisted, was responsible for the 1918 pandemic Spanish flu.

It was speculated Moshe worked for Israel’s Mossad.

In late October of 2009, Ukraine was hit by an especially aggressive and virulent form of hemorrhagic pneumonia. “The virus appears to be either a highly aggressive mutation of the globally-circulating H1N1 strain, or a combination of three different influenza strains now circulating in Ukraine,” Mike Adams wrote at the time.

“Moshe claimed that Baxter’s laboratory in the Ukraine out of all places was creating this biological weapon. All of this came out in the beginning of August, which is more than 2 months before the situation that is currently unfolding [in Ukraine]. For Moshe to correctly name the country where a new epidemic would be unleashed, requires either inside information, or an incredible coincidence as anyone with a basic knowledge of statistics can confirm for himself,”David Rothscum wrote on October 31.

The H1N1 flu “pandemic” turned out to be mostly government and media hype. It was later said the United Nations’ World Health Organization had connived with Baxter, GlaxoSmithKline, Novartis, and Sanofi-Aventis to create a pandemic scare in order to sell vaccines.

In January of this year, the WHO insisted it was not unduly influenced by drug companies to exaggerate the dangers of the H1N1 flu virus. The WHO subsequently appointed a committee to investigate the allegations but its credibility suffered a serious blow when it was learned Dr. John Mackenzie would be included in the investigation. Mackenzie has direct links with several vaccine and pharmaceutical companies and was influential in the WHO declaration of a level 6 pandemic in 2009.

At the time, some 200 million doses of H1N1 vaccine and funding of approximately $12 million were pledged to fight the virus.

In February of 2009, Bloombergreported that Baxter had accidentally contaminated samples with the bird flu virus. The contamination was discovered when ferrets at a lab in the Czech Republic died after being inoculated with vaccine made from the samples. The virus material was supposed to contain a seasonal flu virus and was contaminated after “human error,” according to Baxter.

Dan Even, writing for Haaretz, reported earlier this week that a report had linked the deadly Cryptococcus gatti fungus to labs in the United States and the Nes Tziona Biological Institute in Israel. “The report also linked an Israeli American scientist, Dr. Joseph Moshe, to the spread of the fungus,” writes Even.

An outbreak of the fungus killed six people in Oregon and was predicted to move into northern California and possibly farther, according to experts. “No one knows how the species got to North America or how the fungus can thrive in a temperate region,” notes Christine Dell’Amoreof National Geographic News. Cryptococcus gattii is an airborne fungus native to tropical and subtropical regions, including Papua New Guinea, Australia, and parts of South America.

However, much like the H1N1 virus, the threat posed by the “killer” fungus appears to be little more than corporate media sensationalism.

“At its peak, we were seeing about 36 cases per million per year, so that is a very small number,” Christina Hull, an assistant professor of medical microbiology and immunology and of biomolecular chemistry at the University of Wisconsin School of Medicine and Public Health in Madison, told Bloomberg Businessweek on April 30.

Joseph Moshe is currently scheduled for a court hearing on his mental status on August 24, 2010, in California.